Syrs news
WebNews Press Releases Research Reports SEC Filings Insider Monkey Simply Wall St. Syros Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag Syros … WebSyros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA. Show more Ideas
Syrs news
Did you know?
WebMar 29, 2024 · Get Syros Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SYRS and its competitors with MarketBeat's FREE … WebApr 6, 2024 · SYRS: Syros Pharmaceuticals Inc - Stock Price, Quote and News - CNBC New 52 Week Low Today Syros Pharmaceuticals Inc SYRS:NASDAQ EXPORT WATCHLIST + …
Webr/TLRY. Join. • 1 mo. ago. The CANNABIS INDUSTRY has the potential to save many banks in the US and thus prevent a global (worldwide) collapse of financial institutions. The CANNABIS INDUSTRY has a huge pile of cash. 116. 37. r/pennystocks. Join. WebApr 15, 2024 · NASDAQ SYRSopened at $2.70 on Friday. The stock has a market capitalization of $54.81 million, a PE ratio of -0.21 and a beta of 1.67. The business has a 50 day simple moving average of $3.39 and a...
WebSYRS (Syros Pharmaceuticals) Other Long Term Assets as of today (April 14, 2024) is $8.43 Mil. Other Long Term Assets explanation, calculation, historical data WebSep 13, 2024 · Ethereum’s price is currently approaching the resistance level of $2008.0. The Buyers have successfully used the retest of the symmetrical triangle to engineer a bullish displacement. Ethereum experienced double bearish impulsive waves that delivered the price from the high of $3487.0 to the support level of $1009.0.
WebSyros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the grant of restricted stock unit (RSU) awards for an aggregate of 14,200... SYRS : 2.51 (-2.15%) Syros Pharmaceuticals Announces Publication in Blood Advances Demonstrating the Potential of Tamibarotene …
WebApr 9, 2024 · SYRS Stock Overview Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. About the company Rewards Revenue is forecast to grow 58.79% per year Risk Analysis Shareholders have been substantially diluted in the past year streamlined authority codeWebSYRS News on February 2nd. TAMIBAROTENE. Syros Receives FDA Orphan Drug Designation for Tamibarotene for the Treatment of MDS on Feb 2nd. 1. 0 comments. share. save. About Community. Syros Pharmaceuticals is a bio-pharmaceutical that focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of … streamlined authority code pbsWebFeb 2, 2024 · The U.S. Food and Drug Administration granted orphan drug designation to Syros Pharmaceuticals' (SYRS) tamibarotene to treat myelodysplastic syndrome ((MDS)).Tamibarotene is... streamline workflow processesWebCAMBRIDGE, Mass., February 23, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, March 2, 2024 to report its fourth quarter … streamline workspace 3.0WebThe Latest News and Updates in News brought to you by the team at WSYR: streamlined backshop couponWebApr 15, 2024 · Syros Pharmaceuticals Trading Down 2.5 %. Shares of Syros Pharmaceuticals stock opened at $2.70 on Friday. The firm has a market capitalization of … streamline windows brisbaneWebSyros Pharmaceuticals…. Syros Pharmaceuticals presents safety lead-in data from SELECT-AML-1 trial » 12/11/22. SYRS. Syros Pharmaceuticals…. Syros Pharmaceuticals price target lowered to $16 from $40 at JMP Securities » 11/15/22. SYRS. JMP Securities analyst…. Syros Pharmaceuticals price target lowered to $15 from $30 at Oppenheimer ... streamline workflow definition